RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

26 Miles Capital vs Upcomers

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

XXMI

26 Miles Capital

UPCM

Upcomers

EST. 2023

26 MILES CAPITAL

METRIC

UPCOMERS

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

26 MILES CAPITAL DETAILS

STEPS: -phase

UPCOMERS DETAILS

STEPS: -phase

26 Miles Capital PROS

+No data is available on profit split, funding, or cost metrics for this firm
+No data is available on drawdown or profit target for this firm
+No data is available on payout timing or steps to funded for this firm
+No data is available on platforms, markets, or founding date for this firm

26 Miles Capital CONS

−Virtually no data is provided, making any objective evaluation impossible
−Traders cannot compare this firm's terms to the industry average of 84.7% profit split
−Lack of transparency on key metrics is a significant risk for traders making financial decisions

Upcomers PROS

+Czech Republic is an EU-member jurisdiction, which may offer relevant regulatory context for European traders.
+No further data is available to substantiate additional pros at this time.
+No platform or market data is provided to assess trading conditions.
+No funding or cost data is available to compare against industry benchmarks.

Upcomers CONS

−Founded in 2023, making Upcomers a very new firm with minimal operational track record.
−No profit split, drawdown, funding, or challenge cost data is available for industry comparison.
−Lack of transparency around key metrics makes it very difficult for traders to make informed decisions.

PROPDNA VERDICT